MariMed Stock Soar After Impressive First Quarter Results
MariMed Inc (OTCQB:MRMD) share price rose more than 16% after reporting 81% year over year revenue growth for the first quarter. Its stock has hit the all-time high of $1.97 a share amid impressive quarterly ... [Read]
Heat Biologics Inc. Reports Q1 Results – Shares Jump +10%
Shares of the North Carolina-based biopharmaceutical company Heat Biologics Inc. (NASDAQ:HTBX) jumped up over 10% on Tuesday after the company released its first-quarter financial results. Heat Biologics focusses mainly on creating drugs for the treatment ... [Read]
Arrowhead Pharmaceuitcals Releases Quarterly Results – Shares Jump Over 10%
Shares of the California-based biotechnology company Arrowhead Pharmaceuticals (NASDAQ:ARWR) rose over 10% after the company released its second-quarter results of 2018. The company saw a decrease in revenue compared to the previous year, falling from ... [Read]
VIVUS Inc. to Acquire PANCREAZE Capsules – Shares Skyrocket
Shares of the biopharmaceutical company VIVUS Inc. (NASDAQ:VVUS) skyrocketed on Tuesday after the company announced that they had entered into an agreement to purchase all rights to PANCREAZE (pancrelipase) Delayed-Release Capsules from Janssen Pharmaceuticals, Inc. ... [Read]
Celldex Shares Fall Over 60% After Failed Drug Study
Shares of the biotechnology company Celldex Therapeutics Inc. (NASDAQ:CLDX) have fallen over 60% today after the company announced that its study in Metastatic Triple-negative Breast Cancer failed to reach the targeted endpoint. The phase 2b ... [Read]
Geron Corporation Trading Higher In Anticipation of Johnson&Johnson Q1 Report
The stock market is in full swing, and one of the trending tickers of the day is a small-cap oncology company that has ties to Johnson & Johnson (NYSE:JNJ). Who’s the lucky winner? Well, it’s ... [Read]
Verastem Inc Shares Rise – New Drug Application Accepted by FDA
Shares of the biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) were on the rise on Monday after the company announced that the United States Food and Drug Administration (FDA) had accepted their New Drug Application (NDA) for ... [Read]
Shares of Menlo Therapeutics Plummet By 70%
Shares of the biopharmaceutical company Menlo Therapeutics Inc. (Nasdaq:MNLO) have plummeted by nearly 70%. The loss of share value is due to the company releasing the results of their Phase 2 Trial of ‘Serlopitant’ for ... [Read]
EyeGate Pharmaceuticals – Stock Up Nearly 25%
Shares of Massachusetts-based EyeGate Pharmaceuticals (Nasdaq:EYEG) have gone up nearly 25% after the company announced the enrollment confirmation of the Phase 3 Clinical Study of EGP-437 in Anterior Uveitis. The trial is meant “to assess ... [Read]
HealthSpace Announces New USD$3.064 Million SaaS Contract – the Largest in Company History
VANCOUVER, April 4, 2018 /CNW/ – HealthSpace Data Systems Ltd. (the “Company” or “HealthSpace”) (CSE:HS) (FRA: 38H) announces that the Virginia Department of Health (“VDH”) has signed a five year contract for the Office of ... [Read]